1型糖尿病儿童及青少年早期使用持续葡萄糖监测:启动率及对血糖结局的影响
该多中心研究基于T1D Exchange质量改进协作组25家儿科中心的电子健康记录,纳入2019至2020年诊断的≤18岁1型糖尿病儿童及青少年共4164人,随访诊断后3年。93%在3年内启动持续葡萄糖监测(CGM),其中21%在0-3个月启动。诊断后3年,0-3个月和3-6个月启动组的中位HbA1c低于6-12个月组及未使用CGM组。结论认为诊断后前6个月内早期启动CGM与3年时HbA1c改善相关。
要点
- 诊断后0-3个月和3-6个月启动CGM组3年时中位HbA1c均为7.9%,低于6-12个月组的8.4%和未使用CGM组的9.5%。
- 校正混杂因素后,HbA1c>9%的比值比在0-3个月启动组最低,其次为3-6个月启动组。
- 93%(n=3877)在诊断后3年内启动CGM,其中51%在12个月后启动。
核心结论
- 诊断后前6个月内早期启动CGM与诊断后3年时HbA1c结局改善相关。
研究设计与样本
- 多中心研究,数据来自T1D Exchange质量改进协作组(T1DX-QI)电子健康记录数据库,涵盖25家儿科中心。
- 纳入2019年和2020年诊断的≤18岁1型糖尿病儿童及青少年,共4164人,平均年龄12.6岁(SD 3.5),37%拥有公共医疗保险。
- 随访诊断后3年内的CGM启动情况及血糖结局,采用局部估计散点图平滑评估CGM启动时机与HbA1c随时间的关系,并使用逻辑回归模型校正潜在混杂因素。
主要发现
- 93%(n=3877)在诊断后3年内启动CGM,其中21%在0-3个月启动,14%在3-6个月启动,14%在6-12个月启动,51%在12个月后启动。
- 诊断后3年时中位HbA1c:0-3个月组7.9%,3-6个月组7.9%,6-12个月组8.4%,未使用CGM组9.5%。
- 校正后HbA1c>9%的比值比在0-3个月启动组最低,其次为3-6个月启动组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Early initiation of continuous glucose monitor (CGM) after type 1 diabetes (T1D) diagnosis has been associated with lower hemoglobin A1C (HbA1c) in single-institution studies. This multicenter study evaluated the association between the timing of CGM initiation and HbA1c at 3 years postdiagnosis. RESEARCH DESIGN AND METHODS: Data were obtained from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) electronic health record database from 25 pediatric centers and included children and adolescents ≤18 years old diagnosed with T1D in 2019 and 2020. CGM initiation and glycemic outcomes were followed for 3 years after diagnosis. Locally estimated scatterplot smoothing plots evaluated the relationship between timing of CGM initiation and HbA1c over time, and logistic regression models were used to adjust for potential confounders. RESULTS: There were 4,164 people included in this analysis, mean age was 12.6 (SD 3.5) years, and 37% had public health insurance. Of the 93% (n = 3,877) who initiated CGM within 3 years of T1D diagnosis, 21% did so at 0-3 months, 14% at 3-6 months, 14% at 6-12 months, and 51% after 12 months. Median HbA1c at 3 years postdiagnosis was lower for the 0-3 and 3-6 months groups compared with the 6-12 months and non-CGM user groups (7.9%, 7.9%, 8.4%, and 9.5%, respectively). Adjusted odds of HbA1c >9% were lowest for the 0-3 months group followed by the 3-6 months group. CONCLUSIONS: In summary, early initiation of CGM within the first 6 months of diagnosis is associated with improved HbA1c outcomes at 3 years postdiagnosis.
引用
- Mann EA, Rompicherla S, Miyazaki B, et al. Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025. PMID: 40009551. doi:10.2337/dc25-0076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。